Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).
暂无分享，去创建一个
F. Saad | J. Hainsworth | J. Carles | H. Scher | C. Higano | E. Small | C. Logothetis | Y. Park | D. Rathkopf | P. Mainwaring | P. Mulders | E. Yu | T. Flaig | M. Taplin | K. Fizazi | P. de Souza | T. Beer | E. Efstathiou | C. Ryan | J. D. de Bono | H. Van Poppel | T. Griffin | Y. Fradet | Margaret K Yu | N. Shore | Matthew R. Smith | A. Molina | S. North | T. Kheoh | M. Todd